{
	"img": {
		"0": {
			"alt_text": "Dr. Collin Blakely",
			"file_name": "blakely.jpg"
		}
	},
	"intro_text": "Researcher Collin Blakely from the University of California San Francisco studies why some lung cancers don’t respond well to targeted therapy and he works to discover more effective treatments.",
	"pageRoute": "/research/blakely-improving-responses",
	"pageTitle": "Improving responses to lung cancer treatments",
	"sections": {
		"0": {
			"body": "The focus of my research at UCSF is to learn why some lung cancers don’t respond well or only respond partially to targeted therapy. For instance, what is the role of a tumor’s genetics or the immune system on response to therapy? I study lung cancer tumor samples to find new treatments that may work when other drugs stop working.",
			"title": "What are the top goals of your research?"
		},
		"1": {
			"body": "I am mostly inspired by my patients, who are in desperate need of new treatments. I’m also driven by my own curiosity and the drive to make new discoveries that push the limits of our knowledge.",
			"title": "What inspires you to be a researcher?"
		},
		"2": {
			"body": "I would like to better understand why some people don’t completely respond to lung cancer treatments. I hope to use the results of my research to plan new clinical trials testing different drugs on people with lung cancer.",
			"title": "How would Biobank samples help your research?"
		}
	}
}
